ABC News, 24/11/16 The Greens want South Australia to be part of a trial for a pill which can reduce the risk of HIV infection and is already being widely used overseas. The drug called PrEP — short for pre exposure prophylaxis — is made up of antiretroviral drugs taken by HIV-negative people to prevent HIV infection, according to the ACON website, which is primarily funded by the NSW Ministry of...
A sexual health clinic in London has tested drug levels in users of generic PrEP medication bought online and found the drugs are genuine and effective.
Tests found adequate levels of both emtricitabine and tenofovir (used in PrEP medication Truvada) in patients’ blood, and no sample suggesting counterfeit drugs.
Read more here
See conference program here
Journal of the International AIDS Society 2016, 19:21165 Abstract: Introduction: An estimated 1.2 million Americans have indications for using antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV acquisition. For many of these at-risk individuals, the best opportunity to learn about and receive PrEP will be during routine visits to their generalist primary care clinicians. However, few...
BETA Blog, September 8, 2016 How many doses of Truvada-based PrEP (pre-exposure prophylaxis) are needed to provide adequate protection against HIV? Might it be possible to take PrEP only before and after sex—instead of every day? A recent article published in The Lancet HIV provides insight into this very question. Read more here Access Lancet HIV abstract here (for full text please see your...
Australian Federation of AIDS Organisations (AFAO), 23 August, 2016 Following the Pharmaceutical Benefits Advisory Committee (PBAC) decision not to recommend funding PrEP through the Pharmaceutical Benifits Scheme (PBS), AFAO has produced an Australian PrEP roundup paper to sustain advocacy efforts and to raise awareness about current options for accessing PrEP around the country. In releasing...
6 MAY 2016 — The Victorian AIDS Council (VAC) The Victorian AIDS Council (VAC) has welcomed the news today that the Therapeutic Goods Administration (TGA) has approved the drug Truvada for use as PrEP (pre-exposure prophylaxis for HIV) in Australia. TGA approval means doctors in Australia no longer have to prescribe Truvada as PrEP “off-label”, that is, for something other than its previously...